The flesh-eating screwworm has returned to the southern U.S. for the first time since 1966. The USDA is employing sterile-fly biological control methods and detection dogs to manage the threat to livestock and public health.
Kenji··2 min read
The USDA confirms the first flesh-eating screwworm outbreak in the U.S. since 1966, launching urgent containment efforts using biological controls.
Kenji··1 min read
A new oral drug, Daraxonrasib, has shown significant potential in clinical trials, nearly doubling survival times for patients with advanced RAS-mutated pancreatic cancer.
Williams··2 min read
The Ebola outbreak in the DR Congo has escalated to over 1,000 cases and 200 deaths, with the WHO warning of alarming, rapid transmission rates.
Kenji··2 min read
An Ebola outbreak in the Democratic Republic of Congo is causing international alarm, with resource shortages hindering efforts and mandatory isolation impacting the national football squad's World Cup participation.
Williams··2 min read
A rare Ebola strain is spreading in Congo, straining local health infrastructure and triggering global concern regarding public health readiness.
Williams··2 min read
Recent evidence supports universal screening for childhood type 1 diabetes to improve detection rates. This shift advocates for proactive pediatric care and data-linked monitoring.
Williams··2 min read
Researchers are adapting CAR-T cell therapy, a breakthrough in cancer treatment, to target HIV viral reservoirs, offering new potential for long-term viral control and remission.
Williams··2 min read
CAR T-cell therapy, traditionally used for cancer, is being successfully adapted to treat complex autoimmune diseases by 'resetting' the immune system, showing great promise in recent clinical studies.
Williams··2 min read
Health authorities have confirmed an Ebola outbreak in Congo and Uganda with an uncommon strain, prompting an urgent international response to contain the spread.
Kenji··2 min read
Reports of a single-injection therapy reversing osteoarthritis damage lack robust clinical evidence, as researchers emphasize the need for caution and further clinical validation.
Williams··2 min read
Recent research reveals an accuracy trade-off when designing AI chatbots to be warmer and friendlier. Prioritizing empathetic personas over analytical rigor can lead to reduced factual reliability, posing risks in high-stakes fields like healthcare.
Williams··2 min read
At WIRED Health, expert Ara Darzi highlighted AI's potential to revolutionize the diagnosis and treatment of drug-resistant infections, while noting that a lack of economic incentives for drug discovery remains a major barrier.
Williams··2 min read
A lawsuit in California against a medical AI transcription tool has sparked concerns over patient privacy and data security. The allegations highlight the lack of sufficient regulation and informed consent for the off-site processing of sensitive medical interactions.
Mark··2 min read
The growth of AI health and influencer bots presents significant risks, including poor medical advice, the misuse of sensitive health data, and the reinforcement of harmful social stereotypes.
Williams··2 min read
U.S. healthcare policy is in a state of flux, with concerns over anti-vaccine influence entering CDC policy-making, while pharmaceutical companies use redefinition strategies to survive a polarized environment.
Williams··2 min read